NYMXFOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
NYMOX PHARMACEUTICAL CORP
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Sep 14, 2026
$0.04+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Nymox Pharmaceutical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Nymox Pharmaceutical filed with the SEC
Transcript of Special Shareholders Meeting Aug 28 2026
EX-99.1 to Form 6-K
NOTICE OF SPECIAL MEETING OF THE SHAREHOLDERS
EX-99.1 to Form 6-K
For more information please contact [email protected] or 800-936-9669.
EX-99.1 to Form 6-K
Nymox Announces Dismissal of Delaware Action Against Ascella
EX-99.1 to Form 6-K
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
EX-99.1 to Form 6-K
For more information please contact [email protected] or 800-936-9669.
EX-99.1 to Form 6-K
Nymox Required to Resubmit Application to DKMA
EX-99.1 to Form 6-K
Office of the Chief Accountant
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
EX-99.1 to Form 6-K
N E W S RELEASE
EX-99.1 to Form 6-K
Nymox Reports Completion of $2 Million Private Placement
EX-99.1 to Form 6-K
Nymox Announces $2 Million Private Placement
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.2 to Form 6-K
EX-99.2 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
For more information please contact [email protected] or 800-936-9669 .
EX-99.1 to Form 6-K
MANAGEMENT’S DISCUSSION AND ANALYSIS (in US dollars)
EX-99.1 to Form 6-K
I, Christopher Riley, CFO of Nymox Pharmaceutical Corporation, certify that:
EX-99.3 to Form 6-K
I, Randall J, Lanham, COO of Nymox Pharmaceutical Corporation, certify that:
EX-99.3 to Form 6-K
I, Randall J, Lanham, COO of Nymox Pharmaceutical Corporation, certify that:
EX-99.3 to Form 6-K